Navitor Transcatheter Aortic Valve System

Abbott's next-generation self-expanding transcatheter aortic valve system (FDA approved January 2023) for severe, symptomatic aortic stenosis, featuring an active sealing cuff designed to conform to irregular, calcified annular anatomy and reduce paravalvular leak, with full repositioning capability during implantation.

Approval Date

January 2023